Literature DB >> 15198146

von Hippel-Lindau disease with bilateral multiple renal cell carcinoma managed by right radical nephrectomy and left repeat partial nephrectomy.

M S Ansari1, N P Gupta, Pawan Kumar.   

Abstract

von Hippel-Lindau (VHL) disease is an autosomal dominant disorder characterized by cysts and cystadenoma in the kidney, pancreas and epididymis and angiomas of the central nervous system and retina as well as renal cell carcinoma (RCC), phaeochromocytoma, islet tumors of the pancreas, and endolympatic sac tumors. VHL for its multicentric-characteristic and bilateralism often puts the surgeon in challenging situation. We present a case of VHL with bilateral RCC and retinal angiomas managed with right radical nephrectomy and left repeat partial nephrectomy.

Entities:  

Mesh:

Year:  2003        PMID: 15198146     DOI: 10.1023/b:urol.0000025633.40416.57

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  3 in total

1.  [A case of renal cell carcinoma associated with von Hippel-Lindau disease and the necessity for family genetic diagnosis].

Authors:  M Nanri; M Uda; Y Iguchi; N Gouya; H Toma; T Kihara
Journal:  Hinyokika Kiyo       Date:  1999-11

2.  Management of renal cell carcinoma in von Hippel-Lindau disease.

Authors:  F J Hes; P J Slootweg; T J van Vroonhoven; R J Hené; M A Feldberg; R A Zewald; J K Ploos van Amstel; J W Höppener; P L Pearson; C J Lips
Journal:  Eur J Clin Invest       Date:  1999-01       Impact factor: 4.686

3.  [Treatment of von Hippel-Lindau disease with renal involvement].

Authors:  Y Chrétien; D Chauveau; S Richard; D Droz; J M Correas; A Mejean; B Dufour; J P Grünfeld
Journal:  Prog Urol       Date:  1997-12       Impact factor: 0.915

  3 in total
  2 in total

Review 1.  Management of locally recurrent kidney cancer.

Authors:  Eric A Singer; Gennady Bratslavsky
Journal:  Curr Urol Rep       Date:  2010-02       Impact factor: 3.092

2.  Feasibility and outcomes of repeat partial nephrectomy.

Authors:  Aaron Johnson; Sunil Sudarshan; Jack Liu; W Marston Linehan; Peter A Pinto; Gennady Bratslavsky
Journal:  J Urol       Date:  2008-05-15       Impact factor: 7.450

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.